AMBIOPHARM
AmbioPharm is a manufacturing company that manufactures active pharmaceutical ingredients and generic peptides. It undertakes development and production of research-grade complex peptide generic pharmaceuticals and active pharmaceutical ingredients for pre-clinical in-vitro, medicinal, and toxicology programs through its responsive business model and rapid manufacturing processes that enable pharmaceutical and biotech companies to take their peptide projects from preclinical and clinical to commercial quickly at lower costs.
AMBIOPHARM
Industry:
Biotechnology Innovation Management Manufacturing
Founded:
2005-01-01
Address:
North Augusta, South Carolina, United States
Country:
United States
Website Url:
http://www.ambiopharm.com
Total Employee:
51+
Status:
Active
Contact:
(415) 921-3593
Email Addresses:
[email protected]
Total Funding:
24 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Google Font API Google Tag Manager WordPress SSL By Default Font Awesome ReCAPTCHA
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Bolt Threads
Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future.
Cytek Biosciences
Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
Femasys
Femasys engages in R&D and manufacture of medical devices for women's healthcare.
Gradalis
Gradalis is engaged in manufacturing immunotherapy for the treatment of cancer.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Nascent Biotech
Nascent Biotech is a biotechnology company building a portfolio of innovative therapeutic antibodies.
Norman Biological Technology
Norman Biological Technology is a manufacturer of automated chemiluminescence system.
Simcere Pharma
Simcere Pharma is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market.
Current Employees Featured
Founder
Investors List
The Carlyle Group
The Carlyle Group investment in Private Equity Round - AmbioPharm
MVM Life Science Partners
MVM Life Science Partners investment in Venture Round - AmbioPharm
Newest Events participated
Participated in TIDES: Oligonucleotide and Peptide Therapeutics 2017
on 2017-04-30 as exhibitor
Key Employee Changes
| Date | New article |
|---|---|
| 2023-10-02 | AmbioPharm Appoints Industry Veteran Brian Gregg as CEO |
Official Site Inspections
http://www.ambiopharm.com Semrush global rank: 3.18 M Semrush visits lastest month: 4.69 K
- Host name: cloudproxy10067.sucuri.net
- IP address: 192.124.249.67
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AmbioPharm"
About Us - AmbioPharm
AmbioPharm is capable of efficiently manufacturing peptide of any batch size from milligrams all the way to multi-kilograms and even metric tons. Contract GMP Peptide Manufacturing. A peptide CDMO serving pharmaceutical, โฆSee details»
AmbioPharm - A Global Peptide CDMO - LinkedIn
AmbioPharm - A Global Peptide CDMO | 6,086 followers on LinkedIn. Global Peptide Contract Development & Manufacturing Organization (CDMO). | AmbioPharm, a global peptide CDMO, was founded in 2005 ...See details»
Management Team - AmbioPharm
The management team at AmbioPharm, Inc. has more than two hundred years of cumulative experience in manufacturing Research and Pharmaceutical-grade peptides. ... As CFO, Mr. โฆSee details»
AmbioPharm - Crunchbase Company Profile & Funding
AmbioPharm is a manufacturing company that manufactures active pharmaceutical ingredients and generic peptides. It undertakes development and production of research-grade complex peptide generic pharmaceuticals and โฆSee details»
AmbioPharm Company Profile 2024: Valuation, โฆ
AmbioPharm General Information Description. Operator of a peptide active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) intended for the global pharmaceutical industry.See details»
AmbioPharm - A Global Peptide CDMO | ้ข่ฑ - ้ข่ฑ (ไธญๅฝ)
AmbioPharm - A Global Peptide CDMO | ๅจ้ข่ฑไธๆ 6,133 ไฝๅ ณๆณจ่ ใGlobal Peptide Contract Development & Manufacturing Organization (CDMO). | AmbioPharm, a global peptide CDMO, โฆSee details»
AMBIOPHARM, INC. - PharmaCompass
AmbioPharm, acquired UCB Bioproducts at North Augusta, USA Shanghai AmbioPharm, started at Shanghai, China 2005 2007 2011 AmbioPharm, FDA PAI ... AmbioPharm Organization โฆSee details»
AmbioPharm Company Profile - Office Locations, Competitors
AmbioPharm is a peptide development and manufacturing company. It provides good manufacturing practice (GMP), analytical development and validation, vaccine, cosmetic โฆSee details»
AmbioPharm - Overview, News & Similar companies | ZoomInfo.com
Oct 2, 2023 AmbioPharm Appoints Industry Veteran Brian Gregg as CEO NORTH AUGUSTA, S.C.--(BUSINESS WIRE)-- #cGMP--AmbioPharm, a worldwide leader in peptide active โฆSee details»
AmbioPharm - Contacts, Employees, Board Members, Advisors
AmbioPharm has 4 current employee profiles, including Senior Vice President Business Development Robert Geiger. Robert Geiger Senior Vice President Business Development โฆSee details»
AmbioPharm - Funding, Financials, Valuation & Investors
AmbioPharm is funded by 2 investors. The Carlyle Group and MVM Life Science Partners are the most recent investors. AmbioPharm has a post-money valuation in the range of $50M to โฆSee details»
Peptide Products & Services - AmbioPharm
As an FDA-inspected, USA-based peptide active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO), AmbioPharm has the scale and quality โฆSee details»
Ambio Holdings, Inc. - Carlyle
Ambio is a peptide active pharmaceutical ingredient ("API") contract development and manufacturing organization ("CDMO").See details»
Management Team - Ambio
As Founder and Chairman of the Board, Dr. Bai also provides oversight of Ambiopharm Inc., covering both USA and China operations. Before joining Ambio and AmbioPharm, he was the โฆSee details»
AmbioPharm Inc. Announces New Shanghai Campus Opening and โฆ
Jan 7, 2021 NORTH AUGUSTA, S.C.--(BUSINESS WIRE)--AmbioPharm Inc., a worldwide leader in peptide API CDMO services, has recently opened its new Shanghai campus.The โฆSee details»
AmbioPharm, a Global Peptide CDMO | Business Wire
Jul 26, 2023 The latest addition to the AmbioPharm Shanghai campus brings a total of approximately 380,550 ft 2 (35,354 m 2) of manufacturing and administrative space. The โฆSee details»
Corporate Values | Diversity & Responsibility - AmbioPharm
AmbioPharm seeks to be a truly excellent global corporation. For our partners, we offer the best products possible. Simultaneously, we strive to improve our relationships with local โฆSee details»
Chief Executive Officer, Board Member - AmbioPharm
· Experience: AmbioPharm - A Global Peptide CDMO · Education: San Diego State University-California State University · Location: St Petersburg · 301 connections on LinkedIn.See details»
Peptide Drug Development Experts | Ambio
Expertise. Ambio is the worldโs leading peptide expert with proprietary know-how and unmatched technological advances in the development and manufacturing of novel therapeutics and โฆSee details»